Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Accumulated Expenses (2023 - 2024)

Historic Accumulated Expenses for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Q2 2024 value amounting to $33000.0.

  • Tonix Pharmaceuticals Holding's Accumulated Expenses changed N/A to $33000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $33000.0, marking a year-over-year change of. This contributed to the annual value of $44000.0 for FY2023, which is N/A changed from last year.
  • Latest data reveals that Tonix Pharmaceuticals Holding reported Accumulated Expenses of $33000.0 as of Q2 2024.
  • Over the past 5 years, Tonix Pharmaceuticals Holding's Accumulated Expenses peaked at $44000.0 during Q4 2023, and registered a low of $32000.0 during Q3 2023.